Recently, there have been several molecular studies of trisomic fetuses and liveborns which have examined the parent and meiotic stage of origin of nondisjunction. However, little is known about the possible phenotypic effects of the origin of trisomy. For trisomic spontaneous abortions, no distinct phenotype has been described, although some have been reported to have features, such as trophoblastic hyperplasia, similar to hydatidiform moles. In the present report, we describe molecular and histological studies of spontaneous abortions with trisomies 2, 7, 15, or 22, conditions occasionally linked to trophoblastic hyperplasia.
Trisomy is the most common chromosome abnormality in humans, occurring in about 4% of all clinically recognised pregnancies.' Nearly all trisomic conceptuses miscarry and as many as 25% of all spontaneous abortions are the result of trisomy.'
Most molecular studies of trisomy have focused on the parent and meiotic stage of origin of non-disjunction, using fetuses or liveborns with trisomy 16,2 trisomy 18,' or trisomy 21,4 among others. These studies have shown that most trisomy originates from maternal meiotic non-disjunction and that factors such as abnormal recombination play an important role in its genesis. 5 However, little is known about the phenotypic effects of the origin of trisomy, that is, whether or not the parent or meiotic stage of origin influences the phenotype of the trisomic conceptus. Some data are available from studies of people with Down syndrome and specific phenotypic abnormalities such as leukaemia6 or congenital heart disease.7 These studies have failed to find a relationship between the parental origin of the extra chromosome 21 and either leukaemia or heart disease, but have provided evidence for other, subtler differences in the origin of trisomy. For example, Zittergruen et af suggested that recombination was decreased in meioses leading to Down syndrome with congenital heart defects by comparison with cases without heart disease and Shen et at suggested that Down syndrome patients with leukaemia were more likely to be homozygous for regions of chromosome 21 than were Down syndrome patients without leukaemia.
As an alternative approach, we have been interested in examining trisomies in spontaneous abortions to determine whether there might be a relationship between the origin of trisomy and the placental phenotype of the abortus. We have been especially interested in studying the parental origin of trisomy since it is clear that there is a "genome wide" parent of origin effect on placental phenotype. That is, studies have shown that the paternal genomic imbalance in androgenetic diploid and diandric triploid conceptuses may lead to the development of complete and partial hydatidiform moles, respectively, spontaneous abortions characterised by hydropic changes in chorionic villi, and proliferation of trophoblastic tissues.8'-" Thus, genomic imprinting clearly plays a significant role in determining the phenotype of complete and partial molar pregnancies.
Similar to the situation for hydatidiform moles, we hypothesised that genomic imprinting might play a role in the placental phenotype of trisomy; that is, for chromosomes having imprinted loci, the presence of two paternal and one maternal chromosomes might lead to molar changes. " In this event, increased dosage of a single paternal chromosome, rather than of the entire haploid set as seen in androgenetic diploidy and diandric triploidy, would be responsible for the molar phenotype.
Changes in placental morphology alone, or with respect to the origin of the additional chromosome, have not been clearly defined for trisomies. Nevertheless interpretation (B4-B6);previous studies conducted in our laboratory indicate that, in the presence of such "sharing" of maternal andfetal alleles at each offive or more microsatellite markers, the trisomy is virtually always maternally derived. Determinations of the stage of origin were similar to those for the complete families; that is, non-reduction at a pericentromeric marker indicated a meiosis I error (Bl and B4), reduction at a pericentromeric marker but non-reduction at another marker(s) a meiosis II error (B2 and BS), and reduction at all markers a mitotic error (B3 and B6). Note that in making determinations for the paternally derived cases, we assumed that the father was heterozygous at all loci.
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among paternally or maternally derived cases (table 3) . The results of the DNA studies on the mechanism of origin of trisomy were also compared with the histological observations to determine whether there was an association between the stage of origin of non-disjunction and placental phenotype. We observed no obvious difference in the frequencies of trophoblastic hyperplasia, fetal tissue, nucleated red blood cells, or hydropic villi in trisomies of meiosis I, meiosis II, or mitotic origin. In addition, the sex chromosome constitution for each trisomic abortus was compared with the histological observations for placental phenotype. There was no difference in the frequency of any phenotypic feature between XX and XY trisomies, suggesting that the sex chromosomes do not play a major role in placental phenotype.
Finally, we compared the results of the DNA studies with the histological evaluation for age of development of the abortus (table 4) . There was no obvious association between developmental age and the stage of origin of trisomy. However, we observed a significant increase in the proportion of paternally derived cases which aborted early (<6 weeks or 6.0-8.5 weeks); eight of nine (89%) paternally derived cases were evaluated as less than 8.5 weeks compared to 26 of 54 (48%) maternally derived cases (W'=5.75, p<0.05). While the small sample size precluded formal analysis of individual trisomies, this trend was observed for each of the four trisomies.
Discussion

NON-DISJUNCTION OF AUTOSOMAL TRISOMIES
While the primary purpose of this study was to analyse parental origin effects on phenotype, it also generated information on the stage of origin of non-disjunction for trisomies 2, 7, 15, and 22, and provides further evidence for chromosome specific non-disjunction patterns.
In previous studies of autosomal trisomies 16, 18 , and 21, it has been shown that nondisjunction predominately originates from maternal meiosis L"2A This study, surveying a larger collection of cases, confirms our earlier report that this is also true for trisomies 15 and 22.21 However, the results of the present study suggest different aetiologies for trisomies 2 and 7. Trisomy 2 was found to have a substantial paternal contribution and more than half of the cases of trisomy 7 originated from mitotic nondisjunction. This latter observation is consistent with molecular studies of eight pregnancies with confined placental mosaicism of trisomy 7, in which seven cases resulted from a somatic error and one case was the result of a maternal meiosis I error.28 ORIGIN there may be a number of mechanisms leading to trophoblastic hyperplasia, some involving imprinted loci and others simply involving the overexpression of non-imprinted loci. It is possible that those involving imprinted loci do not depend on the overexpression of paternally expressed loci but are related to the underexpression of maternally expressed loci. Both types of dosage imbalance are present in androgenetic diploid and diandric triploid moles but which of the two is responsible for the abnormal phenotype is uncertain. In chromosomally normal conceptions, paternal and maternal contributions are equivalent, but in complete moles and triploids these relationships are altered. In androgenetic diploid and diandric triploid moles, paternal contributions represent all and two-thirds of the genome, respectively, while maternal contributions are decreased to none and to one-third, respectively. In the present study on trisomy we have focused on the effect of increased dosage of paternal genetic material. In paternally derived trisomies, the paternal contribution is increased by a single chromosome compared to that of normal diploid conceptions and the maternal contribution to the entire genome remains essentially the same. Thus, our approach tests only for the effect of increased dosage of paternally expressed loci and not for a decrease of maternally expressed loci. Our results indicate that this type of imbalance is insufficient to cause trophoblastic hyperplasia.
An alternative approach to test whether or not the underexpression of a single imprinted chromosome might play a role in abnormal placental phenotype would be to screen for uniparental disomy 
